• Product NameEfinaconazole
• Brief DescriptionInhibitors
• Purification99.70%
• Biological ActivityEfinaconazole(KP-103) is a novel triazole antifungal drug currently under development as a topical treatment for onychomycosis.
• Target NameAntifungal inhibitor
• CAS No. 164650-44-6
• Calculated MW 348.34
• Formulation C18H22F2N4O
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3
  Pathways:Microbiology&virology
  Receptor:Antifungle
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Tatsumi Y, et al. Antimicrob Agents ChemOthers. 2013 May;57(5):2405-9.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting